|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 207/08 | |
| C07D 207/09 |
| (11) | Number of the document | 2771006 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12842776.2 |
| Date of filing the European patent application | 2012-10-22 | |
| (97) | Date of publication of the European application | 2014-09-03 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/061249 |
| Date | 2012-10-22 |
| (87) | Number | WO 2013/062878 |
| Date | 2013-05-02 |
| (30) | Number | Date | Country code |
| 201161552200 P | 2011-10-27 | US |
| (72) |
YASUDA, Nobuyoshi, US
LIU, Zhuqing, US
ZHONG, Yong-Li, US
CHUNG, John, Y. L., US
DUNN, Robert, F., US
MALONEY, Kevin, M., US
CAMPOS, Kevin, US
HOERRNER, R. Scott, US
LYNCH, Joseph, US
XU, Feng, US
CLEATOR, Edward, GB
GIBSON, Andrew, GB
KEEN, Stephen, GB
LIEBERMAN, Dave, GB
YOSHIKAWA, Naoki, JP
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | PROCESS FOR MAKING BETA 3 ANGONISTS AND INTERMEDIATES |
| PROCESS FOR MAKING BETA 3 ANGONISTS AND INTERMEDIATES |